HCPCS Level IIdrugActive
J7639
Dornase alfa non-comp unit
BETOS: D1G
Effective: 2009-01-01
Referenced in 2 policies
Description
Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Pulmozyme
Manufacturer
Genentech, Inc.
HCPCS Dosage
1 MG
Billing Units
2.5000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.